These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20628121)

  • 21. Asymmetric oro-facial angioedema following alteplase for acute ischaemic stroke.
    Wu TY; Wei DY; Baker Y; Sharkey B; Frith RW
    J Clin Neurosci; 2014 Nov; 21(11):2004-6. PubMed ID: 24974191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
    Schwamm LH; Fonarow GC
    N Engl J Med; 2008 Dec; 359(26):2840; author reply 2841. PubMed ID: 19115490
    [No Abstract]   [Full Text] [Related]  

  • 24. Researchers say they will send unpublished alteplase data to UK drug regulator on request.
    Cohen D; Macdonald H
    BMJ; 2015 Jan; 350():h119. PubMed ID: 25575684
    [No Abstract]   [Full Text] [Related]  

  • 25. Thrombolysis 3 to 4.5 hours after acute ischemic stroke.
    Fitzpatrick AE; Noone I; O'Shea DD
    N Engl J Med; 2008 Dec; 359(26):2840; author reply 2841. PubMed ID: 19115491
    [No Abstract]   [Full Text] [Related]  

  • 26. And why not thrombolysis in the ambulance (at least for some)?
    Rosenberg G; Steiner I
    Neurology; 2016 Jul; 87(2):214-9. PubMed ID: 27306629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time Extended for Use of Image-Guided Intravenous Alteplase After Stroke.
    Potera C
    Am J Nurs; 2019 Aug; 119(8):13. PubMed ID: 31356310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large Vessel Occlusion Strokes After the DIRECT-MT and SKIP Trials: Is the Alteplase Syringe Half Empty or Half Full?
    Nogueira RG; Tsivgoulis G
    Stroke; 2020 Oct; 51(10):3182-3186. PubMed ID: 32912092
    [No Abstract]   [Full Text] [Related]  

  • 31. Routine thrombolysis with intravenous tissue plasminogen activator in acute ischaemic stroke patients aged 80 years or older: a single centre experience.
    Uyttenboogaart M; Schrijvers EM; Vroomen PC; De Keyser J; Luijckx GJ
    Age Ageing; 2007 Sep; 36(5):577-9. PubMed ID: 17405776
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy of cerebral thrombolysis in an extended 'time window'.
    Sobolewski P; Kozera G; Kaźmierski R; Michalak S; Szczuchniak W; Nyka W
    J Clin Pharm Ther; 2015 Aug; 40(4):472-6. PubMed ID: 26059848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current acute stroke trials and their potential impact on the therapeutic time window.
    Schellinger PD; Köhrmann M
    Expert Rev Neurother; 2012 Feb; 12(2):169-77. PubMed ID: 22288672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orolingual angioedema with alteplase administration for treatment of acute ischemic stroke.
    Gorski EM; Schmidt MJ
    J Emerg Med; 2013 Jul; 45(1):e25-6. PubMed ID: 23664196
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of alteplase beyond 3 hours of ischemic stroke onset.
    Powers CM
    Adv Emerg Nurs J; 2011; 33(1):65-70. PubMed ID: 21317699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of tissue plasminogen activator dose and interval on stroke severity.
    Nedelman CB; Glenn LL
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):197-8. PubMed ID: 24291014
    [No Abstract]   [Full Text] [Related]  

  • 37. Stroke: The question of alteplase dose for stroke is not resolved.
    Aoki J; Kimura K
    Nat Rev Neurol; 2016 Jul; 12(7):376-7. PubMed ID: 27340023
    [No Abstract]   [Full Text] [Related]  

  • 38. Response to "Effect of tissue plasminogen activator dose and interval on stroke severity".
    Sahlas DJ; Gould L; Swartz R; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):198. PubMed ID: 24291015
    [No Abstract]   [Full Text] [Related]  

  • 39. Stroke treatment: metrics and processes.
    André C
    Arq Neuropsiquiatr; 2015 Jun; 73(6):474-5. PubMed ID: 26083880
    [No Abstract]   [Full Text] [Related]  

  • 40. The smoking-thrombolysis paradox and acute ischemic stroke.
    Fisher M
    Neurology; 2006 Feb; 66(3):458; author reply 458. PubMed ID: 16476964
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.